Andere Kunden interessierten sich auch für
![The Brain Without Oxygen]( "The Brain Without Oxygen")
The Brain Without Oxygen116,99 €![Neuronal and Vascular Plasticity]( "Neuronal and Vascular Plasticity")
Neuronal and Vascular Plasticity116,99 €![Cerebral Ischemia and Calcium]( "Cerebral Ischemia and Calcium")
Cerebral Ischemia and Calcium75,99 €![Neuronal and Vascular Plasticity]( "Neuronal and Vascular Plasticity")
Neuronal and Vascular Plasticity116,99 €![The Cell Cycle in the Central Nervous System]( "The Cell Cycle in the Central Nervous System")
The Cell Cycle in the Central Nervous System148,99 €![Maturation Phenomenon in Cerebral Ischemia V]( "Maturation Phenomenon in Cerebral Ischemia V")
Maturation Phenomenon in Cerebral Ischemia V75,99 €![Cerebral Ischemia and Basic Mechanisms]( "Cerebral Ischemia and Basic Mechanisms")
Cerebral Ischemia and Basic Mechanisms110,99 €
It is well known and researched, that deprivation of oxygen to the brain can quickly result in irreversible damage and death. What is less well known, is that some vertebrate species are exceptionally tolerant of brain hypoxia. The Brain Without Oxygen: Causes of failure - Physiological and molecular mechanisms for survival, Third edition, discusses the mechanisms of brain hypoxia tolerance in these exceptional vertebrates, which include diving marine mammals, high altitude dwellers and the hibernating mammal. Special attention is given to the extraordinary adaptations that allow a few turtle and fish species to tolerate months of brain anoxia.
This third, fully updated edition addresses the potential of these animal models as targets for human clinical intervention. Perhaps the most interesting of these, are those involved in the suppression of metabolic activities to new set points well below their normoxic minima or maintenance levels. This volume will be valuable reading for researchers in physiology, medicine and general biological sciences, and of great importance to pharmaceutical companies researching novel models for stroke and brain ischemia.
This third, fully updated edition addresses the potential of these animal models as targets for human clinical intervention. Perhaps the most interesting of these, are those involved in the suppression of metabolic activities to new set points well below their normoxic minima or maintenance levels. This volume will be valuable reading for researchers in physiology, medicine and general biological sciences, and of great importance to pharmaceutical companies researching novel models for stroke and brain ischemia.